Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study

References

• Tighe MP, Afzal NA, Bevan A, et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009;11:185-202
   PubMedGoogle Scholar
• Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002;109:1061-7
   PubMed Web of Science ®Google Scholar
• Vandenplas Y. Management of paediatric GERD. Nat Rev Gastroenterol Hepatol 2014;11:147-57
   PubMed Web of Science ®Google Scholar
• Vakil N. Disease definition, clinical manifestations, epidemiology and natural history of GERD. Best Pract Res Clin Gastroenterol 2010;24:759-64
   PubMed Web of Science ®Google Scholar
• Ruigómez A, Wallander MA, Lundborg P, et al. Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol 2010;45:139-46
   PubMed Web of Science ®Google Scholar
• Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediat 2005;146(3Suppl):S3-S12
   Web of Science ®Google Scholar
• Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104:1278-95
   PubMed Web of Science ®Google Scholar
• Lightdale JRG, D.A. Section on Gastroenterology, Hepatology and Nutrition. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 2013;131:e1684-95
   PubMed Web of Science ®Google Scholar
• NICE. Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people. 2015; https://www.nice.org.uk/guidance/ng1?UNLID = 77324371120172504154. Accessed 3 June 2016
   Google Scholar
• Romano C, Chiaro A, Comito D, et al. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. Curr Clin Pharmacol 2011;6:41-7
   PubMedGoogle Scholar
• Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817-20
   PubMed Web of Science ®Google Scholar
• Tjon JA, Pe M, Soscia J, et al. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy 2013;33:956-71
   PubMed Web of Science ®Google Scholar
• Saez ME, Gonzalez-Perez A, Gaist D, et al. Risk of seizure associated with use of acid-suppressive drugs: an observational cohort study. Epilepsy Behav 2016;62:72-80
   PubMed Web of Science ®Google Scholar
• Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004;12:171-7
   PubMedGoogle Scholar
• Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393-401
   PubMed Web of Science ®Google Scholar
• O’Neil M, Payne C, Read J. Read codes Version 3: a user led terminology. Methods Inf Med 1995;34:187-92
   PubMed Web of Science ®Google Scholar
• Stuart-Buttle CD, Read JD, Sanderson HF, et al. A language of health in action: Read codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996:75-9
   PubMedGoogle Scholar
• First Databank. Multilex for primary care. http://www.fdbhealth.co.uk/multilex-overview/. Webpage accessed 12 May 2016
   Google Scholar
• Lind T, Rydberg L, Kyleback A, et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:861-7
   PubMed Web of Science ®Google Scholar
• Wilder-Smith C, Backlund A, Eckerwall G, et al. Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study. Clin Drug Investig 2008;28:333-43
   PubMed Web of Science ®Google Scholar
• Wilder-Smith C, Lind T, Lundin C, et al. Acid control with esomeprazole and lansoprazole: a comparative dose-response study. Scand J Gastroenterol 2007;42:157-64
   PubMed Web of Science ®Google Scholar
• Winter H, Gunasekaran T, Tolia V, et al. Esomeprazole for the treatment of gastroesophageal reflux disease (GERD) in infants. Gastroenterol 2009;136(Suppl1):T1123
   Google Scholar
• Gilger MA, Tolia V, Vandenplas Y, et al. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2008;46:524-33
   PubMed Web of Science ®Google Scholar
• Gunasekaran T, Tolia V, Colletti RB, et al. Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study. BMC Gastroenterol 2009;9:84
   PubMed Web of Science ®Google Scholar
• van Pinxteren B, Sigterman KE, Bonis P, et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2010:CD002095
   PubMed Web of Science ®Google Scholar
• Colin-Jones DG. The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995;9(Suppl1):9-14
   Web of Science ®Google Scholar
• Rachel J. van der Pol MJS, van Wijk MP, et al. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 2011;127:925-35
   Web of Science ®Google Scholar
• Johnson DA, Oldfield ECT. Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence. Clin Gastroenterol Hepatol 2013;11:458-64
   PubMed Web of Science ®Google Scholar
• Tolia V, Boyer K. Long-term proton pump inhibitor use in children: a retrospective review of safety. Dig Dis Sci 2008;53:385-93
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2002;35:119-36
   PubMed Web of Science ®Google Scholar
• Hassall EK, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediat 2007;150:262-7
   PubMed Web of Science ®Google Scholar